Nautilus Biotechnology Inc (NAUT) Live Share Price, Invest From India

Nautilus Biotechnology Inc Stock Performance

as on April 11, 2026 at 6:59 am IST

Day's Low
Day's High
$2.83
Day's Price Range
$3.17
$2.96
4.39%
Downside
7.09%
Upside
52 Week's Low
52 Week's High
$0.62
52-Week Price Range
$4.31
$2.96
79.05%
Downside
45.61%
Upside

Nautilus Biotechnology Inc share price movements today

Previous Close: $3.04
Open: $3.17
Volume: 734.5K
Day's Low - High: $2.83 - $3.17
52 Week Low - High: $0.62 - $4.31

Nautilus Biotechnology Inc Historical Returns

1 Month Return: + 25.1 %
3 Month Return: + 47.57 %
1 Year Return: + 311.09 %
3 Year Return: + 11.76 %
5 Year Return: 0 %

Nautilus Biotechnology Inc Stock Fundamentals & Key Indicators

Check Nautilus Biotechnology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$396.1M

EPS (TTM)

-0.55

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-65.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-32.27%

Nautilus Biotechnology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nautilus Biotechnology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Nautilus Biotechnology Inc	BUY	$396.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.4B	132.42%	141.06	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$112.9B	109.41%	28.98	32.94%
Beone Medicines Ltd	NA	$35.9B	NA	126.39	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$82.0B	61.59%	18.69	31.41%

Stock Returns calculator for Nautilus Biotechnology Inc Stock including INR - Dollar returns

The Nautilus Biotechnology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Nautilus Biotechnology Inc investment value today

Current value as on today

₹4,30,543

Returns

₹3,30,543

(+330.54%)

Returns from Nautilus Biotechnology Inc Stock

₹3,00,000 (+300%)

Dollar Impact

₹30,543 (+30.54%)

Analyst Recommendation on Nautilus Biotechnology Inc Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Nautilus Biotechnology Inc. Average target price of $4

Nautilus Biotechnology Inc Share Price Target

Get share price movements and forecasts by analysts on Nautilus Biotechnology Inc.

What analysts predicted

26%UPSIDE

Target Price

Current Price

$2.96

Analyzed by

10 Analysts

Target

$4.00

Nautilus Biotechnology Inc target price $4, a slight upside of 26% compared to current price of $2.96. According to 10 analysts rating.

Nautilus Biotechnology Inc Stock’s Investor Sentiment and Interest

Search interest for Nautilus Biotechnology Inc Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 12, 2026 to April 11, 2026

Change:54% versus previous 30 day period

Nautilus Biotechnology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	8	-	-	-	9	-	-	-	-
Gross Profit	-1	-1	-1	-1	-1	-6	-1	-1	-1	-1
Operating Income	-19	-20	-21	-20	-19	-19	-18	-17	-15	-15
EBITDA	-14	-15	-17	-16	-14	-11	-14	-13	-11	-12
Interest Expense	-	3	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-15	-17	-18	-18	-16	-17	-16	-15	-13	-13
Income Tax Expense	3	-3	1	-	1	-	-	-	-	-
Net Income	-15	-17	-18	-18	-16	-17	-16	-15	-13	-13
Net Profit Margin	0.00%	-207.31%	0.00%	0.00%	0.00%	-183.27%	0.00%	0.00%	0.00%	0.00%

Nautilus Biotechnology Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-2	-2	-3	-5	-6	-6
Operating Income	-15	-50	-63	-76	-81	-66
EBITDA	-13	-47	-54	-74	-64	-52
Interest Expense	-	0	5	-	-	-
Depreciation	2	2	3	5	6	6
Income Before Tax	-15	-50	-57	-63	-70	-59
Income Tax Expense	2	2	5	-	-70	-
Net Income	-15	-50	-57	-63	-70	-59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nautilus Biotechnology Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-17	-18	-18	-16	-17	-16	-15	-13	-13
Operating Cash Flow	-13	-16	-15	-13	-14	-13	-13	-11	-12
Investing Cash Flow	-41	22	14	-7	37	19	14	0	0
Financing Cash Flow	0	0	0	0	0	0	0	-	0
Change in Cash	-54	6	0	-20	23	5	1	-10	-11

Nautilus Biotechnology Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-15	-50	-57	-63	-70	-59
Operating Cash Flow	-9	-13	-39	-45	-51	-59	-50
Investing Cash Flow	4	-25	-138	-25	-43	66	35
Financing Cash Flow	0	75	327	0	0	1	0
Change in Cash	0	36	149	-70	-95	8	-15

Global Institutional Holdings in Nautilus Biotechnology Inc

Funds	Holdings
BlackRock Inc	0.16%
Clarius Group, LLC	0.96%
Crewe Advisors LLC	0.11%
Perceptive Advisors LLC	9.95%
CI Private Wealth LLC	0.25%

See all

Insights on Nautilus Biotechnology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, NAUT stock has moved up by 257.4%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NAUT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 21.6%

About Nautilus Biotechnology Inc

born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.

Organisation	Nautilus Biotechnology Inc
Headquarters	2701 Eastlake Avenue East, Seattle, WA, United States, 98102
Industry	Services
CEO	Mr. Sujal M. Patel
E-voting on shares	Click here to vote

Key Management of Nautilus Biotechnology Inc

Name	Title
Mr. Sujal M. Patel	Co-Founder, CEO, President, Secretary & Director
Dr. Parag Mallick Ph.D.	Co-Founder, Chief Scientist & Director
Mr. Kentaro Suzuki	Chief Marketing Officer
Ms. Anna Mowry	CFO & Treasurer
Mr. Matthew B. Murphy ESQ.	General Counsel
Ms. Amber Faust	Vice President of Global Sales
Ms. Gwen E. Weld	Chief People Officer
Dr. Subra Sankar Ph.D.	Senior Vice President of Product Development

FAQs

What is Nautilus Biotechnology Inc share price today?

Nautilus Biotechnology Inc share price today is $2.96 as on April 11, 2026 at 1:29 am IST at the close of the market. Nautilus Biotechnology Inc share today touched a day high of $3.17 and a low of $2.83.

What is the 52 week high and 52 week low for Nautilus Biotechnology Inc share?

Nautilus Biotechnology Inc share touched a 52 week high of $4.31 on March 25, 2026 and a 52 week low of $0.62 on September 4, 2025. Nautilus Biotechnology Inc stock price today i.e. April 11, 2026 at 1:29 am IST is closed at $2.96,which is 31.32% down from its 52 week high and 377.42% up from its 52 week low.

What is Nautilus Biotechnology Inc's market capitalisation today?

Nautilus Biotechnology Inc market capitalisation is $0.00T as on April 11, 2026 at 1:29 am IST.

How to invest in Nautilus Biotechnology Inc Stock (NAUT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nautilus Biotechnology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nautilus Biotechnology Inc Shares that will get you 0.5068 shares as per Nautilus Biotechnology Inc share price of $2.96 per share as on April 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Nautilus Biotechnology Inc Stock (NAUT) from India?

Indian investors can start investing in Nautilus Biotechnology Inc (NAUT) shares with as little as ₹92.782 or $1 (as of April 11, 2026 at 3:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹927.82 in Nautilus Biotechnology Inc stock (as per the Rupee-Dollar exchange rate as on April 11, 2026 at 3:38 am IST). Based on Nautilus Biotechnology Inc share’s latest price of $2.96 as on April 11, 2026 at 1:29 am IST, you will get 3.3784 shares of Nautilus Biotechnology Inc. Learn more about fractional shares .